Clinical Trials

SEATTLE, WA–(Marketwired – Jun 8, 2017) – CFN Media Group (“CannabisFN”), the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an article discussing Tetra Bio-Pharma Inc. (CSE: TBP) (OTCQB: TBPMF) and its recent progress in bringing its smokeable marijuana therapeutic to market. Medical cannabis has gained widespread acceptance throughout […]

– Top-line data from this study remains on track to report in September 2017 – DEVON, Pa., June 08, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments, today announced that it has met its enrollment target of 16 patients in […]

A rare scientific clinical trial involving cannabis-related compounds has produced stark evidence suggesting the medicinal benefits to be gained through controlled use of medical marijuana. Recently published results from a scientifically-conducted clinical trial show that treating young patients suffering from epilepsy with cannabidiol (“CBD”), a compound derived from marijuana, can significantly reduce and in some […]

Previously, support for medicinal marijuana has been based on anecdotal data. Now there could be science backing it. A new study published on Thursday (NZ time) has found medicine made from a marijuana extract can dramatically cut the number of seizures experienced by children with a severe form of epilepsy. It’s the first time a […]

DEVON, Pa., June 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments, today announced that Zynerba’s Chief Financial Officer, Jim Fickenscher will present a company overview at the Jefferies 2017 Global Healthcare Conference on Thursday, June 8 at 1:30 p.m. […]

A major component of the legal cannabis industry is the CBD market. Matt Karnes of Greenwave Advisors is even more optimistic about the growth of the CBD market saying, “In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now, there are 15 states that allow CBD only – this […]

iStock A landmark clinical trial has shown that a compound in marijuana can ease life-threatening seizures in children with a rare and devastating form of epilepsy. Health24 previously reported that the Western Cape High Court has made a ruling allowing the possession, cultivation and usage of dagga in the home. ‘Gold standard’ evidence Cannabidiol (CBD) […]

A rare scientific clinical trial involving cannabis-related compounds has produced stark evidence suggesting the medicinal benefits to be gained through controlled use of medical marijuana. Recently published results from a scientifically-conducted clinical trial show that treating young patients suffering from epilepsy with cannabidiol (“CBD”), a compound derived from marijuana, can significantly reduce and in some […]

iStock A landmark clinical trial has shown that a compound in marijuana can ease life-threatening seizures in children with a rare and devastating form of epilepsy. Health24 previously reported that the Western Cape High Court has made a ruling allowing the possession, cultivation and usage of dagga in the home. ‘Gold standard’ evidence Cannabidiol (CBD) […]

In May, Drug Enforcement Agency acting administrator Chuck Rosenberg caused a stir by proclaiming, in a speech in Ohio, that “marijuana is not medicine.” Many people immediately disagreed, including The Hill, which wrote that Rosenberg might as well have said “the Earth is flat.” But what’s even more interesting is that the Food and Drug […]

DEVON, Pa., June 01, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid treatments, today announced that Zynerba’s Chief Financial Officer, Jim Fickenscher will present a company overview at the Jefferies 2017 Global Healthcare Conference on Thursday, June 8 at 1:30 p.m. […]

“Seizures in Dravet syndrome are extremely difficult to control and they can be deadly,” says study co-author Linda Laux, MD, from Stanley Manne Children’s Research Institute at Ann Robert H. Lurie Children’s Hospital of Chicago. “Our results are encouraging, especially considering that we don’t have any antiepileptic drugs approved for Dravet syndrome in the U.S.” […]

Time to case the joint?Teryoshi/plainpicture By Andy Coghlan COMPONENTS of cannabis might help those addicted to crack cocaine to quit. Such people may find it easier to curb their usage or give up entirely when they take some form of cannabis, suggests a small study that builds on similar results from research in rodents. “This […]